NCT05570994 2026-01-08177Lu-HTK03170 in mCRPC With PSMA Positive DiseaseBritish Columbia Cancer AgencyPhase 1/2 Enrolling by invitation50 enrolled
NCT04145375 2025-03-19Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 ProtocolZenith EpigeneticsPhase 1/2 Enrolling by invitation40 enrolled